Robert A. Armitage
2012
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $629,012 |
---|---|
Non-Equity Incentive Plan | $955,262 |
Salary | $840,900 |
Stock Awards | $1,500,000 |
Other | $50,454 |
Total | $3,975,628 |
Armitage received $1.5M in stock awards, accounting for 38% of the total pay in 2012.
Armitage also received $629K of change in pension value and nonqualified deferred compensation earnings, $955.3K in non-equity incentive plan, $840.9K in salary and $50.5K in other compensation.
Rankings
In 2012, Robert A. Armitage's compensation ranked 1,655th out of 11,487 executives tracked by ExecPay. In other words, Armitage earned more than 85.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,655 out of 11,487 | 86th |
Division Manufacturing | 590 out of 4,253 | 86th |
Major group Chemicals And Allied Products | 132 out of 1,198 | 89th |
Industry group Drugs | 71 out of 920 | 92nd |
Industry Pharmaceutical Preparations | 60 out of 700 | 91st |
Armitage's colleagues
We found four more compensation records of executives who worked with Robert A. Armitage at Lilly Eli & Co in 2012.
2012
John Lechleiter
Lilly Eli & Co
Chief Executive Officer
2012
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2012
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology and President, Lilly Research Laboratories
2012
Enrique Conterno
Lilly Eli & Co